UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/ approvals in the U.S., Europe, Canada and IsraelATLANTA, Feb. 11, 2025…
RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will…
RIYADH, Saudi Arabia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is enhancing prenatal…
The Period Care Company Emerges from Stealth with Launch of Secure Period Tracking App NASHVILLE, Tenn., Feb. 5, 2025 /PRNewswire/…
Despite 85% of mothers experiencing frequent bladder leaks during postpartum, the survey found only 15% of mothers received resources and…
BOSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…
Regulatory approval follows FemaSeed U.S. FDA-clearance announced September 2023 and EU CE mark approval announced June 2024ATLANTA, Feb. 04, 2025…
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety…
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety…
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety…